Prot# H3B11347: A Randomised Double-Blind, Placebo Controlled, Parallel Group Study to Evaluate the Cognitive Enhancing effect of GSK239512 in Stable Patients with Schizophrenia

Project: Research project

Project Details

StatusFinished
Effective start/end date12/4/0912/4/12

Funding

  • GlaxoSmithKline plc (H3B113147)